amikacin has been researched along with Infections, Respiratory in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (31.94) | 18.7374 |
1990's | 23 (31.94) | 18.2507 |
2000's | 9 (12.50) | 29.6817 |
2010's | 14 (19.44) | 24.3611 |
2020's | 3 (4.17) | 2.80 |
Authors | Studies |
---|---|
Furuno, JP; Graffunder, E; Graves, J; Lodise, TP; Lomaestro, B; McGregor, JC; McNutt, LA; Miller, CD | 1 |
Barzegar, KEF; Barzegar, PEF; Farjanikish, G; Hayati, FZ; Ranjbar, R; Tahmasebi, E; Tebyaniyan, H; Yazdanian, M | 1 |
Abelleira, R; Casal, A; Riveiro, V; Valdés, L | 1 |
Axiotakis, LG; Enver, N; Keating, CL; Pitman, MJ | 1 |
Charbek, E; Rowbotham, NJ; Smith, S | 1 |
Bakker-Woudenberg, IA; der Weide, HV; Goessens, WH; Hays, JP; Ritsema, JA; Storm, G; Te Welscher, YM; van Nostrum, CF | 1 |
Endo, A; Hanawa, K; Hasebe, Y; Isobe, K; Kobayashi, M; Kobayashi, Y; Maebayashi, Y; Naito, A; Nemoto, A; Yamamoto, S | 1 |
Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T | 1 |
Antoniu, S; Azoicai, D | 1 |
Goss, CH; Quon, BS; Ramsey, BW | 1 |
Abuan, T; Flamm, RK; Montgomery, AB; Rhomberg, PR; Walters, KA | 1 |
Ratjen, F; Waters, V | 1 |
Bermudez, LE; Gupta, R; Neville, ME; Rose, SJ | 1 |
Benwill, JL; Wallace, RJ | 1 |
Balducci, AG; Belotti, S; Bettini, R; Buttini, F; Colombo, G; Colombo, P; Politis, S; Rekkas, D; Rossi, A | 1 |
Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
Jahnke, N; Remmington, T; Ryan, G | 1 |
Halacová, M; Kotaska, K; Průsa, R; Vávrová, V | 1 |
de Britto, MC; Magalhães, M; Vandamme, P | 1 |
Bertran, S; Gómez, E; Jiménez de Anta, MT; Julià, A; Ruiz, J; Sauca, G; Vila, J; Vila, X | 1 |
Zagólski, O | 1 |
Petrini, B | 1 |
Lefor, AT; Morita, R; Nabeshima, T; Yoshida, M | 1 |
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
Gilly, R; Grenier, B | 1 |
Ito, T | 3 |
Kitade, M; Moritaka, T; Nakanishi, N; Ueda, N | 1 |
Sanders, CV | 1 |
Ichikawa, Y; Ishibashi, T; Oizumi, K; Takamoto, M; Tamaru, N; Tanaka, H; Tokunaga, N; Toyoshima, H; Watanabe, K; Yoshida, M | 1 |
Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
Beuscart, C; Mouton, YJ | 1 |
Colardyn, F | 1 |
Covi, M; Velluti, G | 1 |
Carbon, C | 1 |
Cuccia, A; O'Riordan, TG; Palmer, LB; Simon, SR; Smaldone, GC | 1 |
Eltahawy, AT | 1 |
Chiodo, F; Ferri, M; Manfredi, R; Nanetti, A | 1 |
Cremades, MJ; Gobernado, M; Menéndez, R; Santos, M | 1 |
Cai, WM; Chu, XM; Dai, YJ; Ling, SS; Rui, JZ; Zhou, YG | 1 |
Ji, S; Wang, R; Wang, Y | 1 |
Agudelo, N; de Vidal, EL; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A; Zapata, CT; Zuluaga, AI | 1 |
Appel, GB; Neu, HC | 1 |
Dooley, RR; Lau, WK; Osher, AB; Young, LS | 1 |
Harada, Y; Ishibashi, T; Takamoto, M; Yamada, H | 1 |
Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A | 1 |
Grunert, K; Koeppe, P; Langmaack, H; Lode, H | 1 |
Agre, K; Berman, E; Gooding, PG; Lane, AZ | 1 |
Hofstetter, A | 1 |
Brumfitt, W; Daikos, GK; Hamilton-Miller, JM; Kosmidis, JC | 1 |
Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
Kluyskens, P; Pauwels, R; Pijck, J; Soep, H; Van Der Straeten, M; Van Nimmen, L | 1 |
Debord, J; Favereau, JP; Gay, C; Gay, R; Lachatre, G; Voultoury, JC | 1 |
Franzus, B; Sarubbi, F; Verghese, A | 1 |
Branger, C; Le Mée, J | 1 |
Giamarellou, H; Moschovakis, E; Petrikkos, G; Sfikakis, P; Vavouraki, E; Voutsinas, D; Yiallouros, K | 1 |
Citerio, P | 1 |
Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A | 1 |
Kamnev, IuV; Kuznetsova, SM; Sokolova, VI | 1 |
Abe, T; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Takino, T; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
Hiraga, Y; Kobayashi, H; Nagahama, F; Nakabayashi, T; Nakayama, I; Onodera, S; Oshitani, H; Saito, A; Sasaki, N; Yoshida, M | 1 |
Hara, K; Hayashi, T; Masuyama, Y; Oda, T; Saito, A; Shigeno, Y; Taira, K; Tomita, H; Yamaguchi, K | 1 |
Kraemer, R; Schaad, UB; Suter, S; Wedgwood-Krucko, J | 1 |
Barrio, JL; Pitchenik, AE; Rodriguez, JL | 1 |
Autret, E; Breteau, M; Grenier, B; Marchand, S | 1 |
Grassi, C | 1 |
Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K | 1 |
Liu, H; Miao, JK; Wan, KX; Wang, DJ; Yang, J; Yu, CW; Yuan, ZJ; Zeng, Y; Zhang, J; Zou, L | 1 |
11 review(s) available for amikacin and Infections, Respiratory
Article | Year |
---|---|
Advances in inhaled antibiotics for management of respiratory tract infections.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Humans; Respiratory Tract Infections | 2023 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Forced Expiratory Volume; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2018 |
Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Bacteria; Cystic Fibrosis; Humans; Liposomes; Pneumonia, Ventilator-Associated; Respiratory Tract Infections | 2013 |
Inhaled antibiotics for lower airway infections.
Topics: Administration, Inhalation; Amikacin; Amphotericin B; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Colistin; Cystic Fibrosis; Gentamicins; Humans; Nebulizers and Vaporizers; Respiratory Tract Infections; Tobramycin | 2014 |
Inhaled liposomal amikacin.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Treatment Outcome | 2014 |
Mycobacterium abscessus: challenges in diagnosis and treatment.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cystic Fibrosis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Genotype; Humans; Molecular Diagnostic Techniques; Molecular Sequence Data; Mycobacterium Infections, Nontuberculous; Polymorphism, Single Nucleotide; Respiratory Tract Infections; Sequence Analysis, DNA; Transcription Factors; Treatment Outcome | 2014 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2012 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Alcaligenes; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Female; HIV-1; Humans; Male; Respiratory Tract Infections | 1997 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; Kidney Diseases; Netilmicin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Sisomicin; Tobramycin; Urinary Tract Infections | 1978 |
Respiratory infections: clinical evaluation.
Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1985 |
18 trial(s) available for amikacin and Infections, Respiratory
Article | Year |
---|---|
Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Facilities; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Leukocyte Count; Long-Term Care; Male; Respiratory Tract Infections; Treatment Outcome | 2007 |
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1994 |
[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Respiratory Tract Infections | 1994 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Retrospective Studies | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Chronic Disease; Colony Count, Microbial; Cross Infection; Cytokines; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intercellular Adhesion Molecule-1; Male; Nebulizers and Vaporizers; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Sputum; Trachea; Tracheostomy | 1998 |
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
Topics: Adult; Aged; Amikacin; Aminoglycosides; Biological Availability; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kanamycin; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Peritonitis; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
A review of results of clinical trials with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Administration Schedule; Enterobacteriaceae; Female; Gram-Negative Bacteria; Hearing; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Respiratory Tract Infections; Serum Bactericidal Test; Urinary Tract Infections | 1991 |
[Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis | 1990 |
[Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Dibekacin; Double-Blind Method; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1987 |
Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Amikacin; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Humans; Oxygen Consumption; Pseudomonas Infections; Respiratory Tract Infections; Vital Capacity | 1987 |
43 other study(ies) available for amikacin and Infections, Respiratory
Article | Year |
---|---|
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Risk; Risk Factors | 2007 |
The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections | 2023 |
Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection.
Topics: Administration, Inhalation; Amikacin; Female; Humans; Laryngoscopy; Larynx; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections | 2021 |
Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Drug Approval; Drug Resistance, Microbial; Humans; Liposomes; Nanomedicine; Particle Size; Respiratory System; Respiratory Tract Infections; Treatment Outcome; United States; United States Food and Drug Administration | 2018 |
Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Body Weight; Brain Stem; Creatinine; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Kidney; Male; Otorhinolaryngologic Diseases; Respiratory Tract Infections | 2019 |
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum | 2019 |
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections | 2014 |
Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection.
Topics: Administration, Inhalation; Aerosols; Amikacin; Animals; Antitubercular Agents; Cell Line; Colony Count, Microbial; Disease Models, Animal; Drug Delivery Systems; Drug Resistance, Bacterial; Female; Humans; Intracellular Space; Liposomes; Lung; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections | 2014 |
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation.
Topics: Administration, Inhalation; Aerosols; Amikacin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cystic Fibrosis; Desiccation; Ethanol; Humans; Motion; Particle Size; Powders; Respiratory Tract Infections; Rheology; Solubility; Surface Properties; Technology, Pharmaceutical; Temperature | 2015 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
[Evaluation of three dosage regimens of amikacin using pharmacokinetic models in patients with cystic fibrosis].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Computer Simulation; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Male; Models, Biological; Pseudomonas Infections; Respiratory Tract Infections | 2004 |
Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
Topics: Amikacin; Anti-Infective Agents; Burkholderia; Burkholderia cepacia complex; Burkholderia Infections; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Infant; Male; Respiratory Tract Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Tobramycin | 2005 |
[Vestibular tests in infants after treatment with aminoglycosides].
Topics: Amikacin; Anti-Bacterial Agents; Drug Combinations; Female; Gentamicins; Humans; Infant; Male; Respiratory Tract Infections; Tobramycin; Vestibular Function Tests | 2005 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
[Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Topics: Adolescent; Amikacin; Azlocillin; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum | 1984 |
[Experimental and clinical studies of intravenous infusion of amikacin in acute respiratory tract infections].
Topics: Acute Disease; Adult; Aged; Amikacin; Drug Evaluation; Female; Hearing Tests; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1982 |
[A case of cystic fibrosis in a Japanese student].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cystic Fibrosis; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Japan; Male; Pseudomonas Infections; Quinolones; Respiratory Tract Infections | 1995 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
Repeated pulmonary infection by Nocardia asteroides complex in a patient with bronchiectasis.
Topics: Amikacin; Anti-Bacterial Agents; Bronchiectasis; Chronic Disease; Drug Therapy, Combination; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia asteroides; Nocardia Infections; Recurrence; Respiratory Tract Infections; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
[Analysis of population pharmacokinetics with NONMEM in clinical patients treated with amikacin by intravenous infusion].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Humans; Infusions, Intravenous; Lung Diseases, Obstructive; Male; Middle Aged; Nonlinear Dynamics; Respiratory Tract Infections | 1996 |
[A series of clinical study on netilmicin].
Topics: Amikacin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Respiratory Tract Infections; Treatment Outcome | 1999 |
Amikacin in gram-negative paediatric infections.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Kanamycin; Klebsiella Infections; Male; Respiratory Tract Infections; Skin Diseases; Urinary Tract Infections | 1978 |
Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Topics: Acute Disease; Adolescent; Adult; Amikacin; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Kanamycin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1977 |
[Clinical evaluation of amikacin for respiratory infections (author's transl)].
Topics: Adult; Aged; Amikacin; Female; Humans; Kanamycin; Male; Middle Aged; Pleural Effusion; Respiratory Tract Infections | 1979 |
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections | 1978 |
[Clinical experience with amikacin for respiratory infections due to gentamicin-resistant bacteria (author's transl)].
Topics: Aged; Amikacin; Drug Resistance, Microbial; Empyema; Female; Gentamicins; Humans; Kanamycin; Lung Abscess; Middle Aged; Respiratory Tract Infections | 1978 |
[Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
Topics: Aged; Amikacin; Female; Humans; Kanamycin; Male; Middle Aged; Respiratory Tract Infections | 1976 |
[New drugs: Amikacin].
Topics: Adult; Amikacin; Child; Drug Therapy, Combination; Humans; Infant, Newborn; Kanamycin; Respiratory Tract Infections; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Micrococcus; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1976 |
Amikacin in the treatment of gram-negative bronchopulmonary infections.
Topics: Acute Disease; Adult; Aged; Amikacin; Enterobacteriaceae Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections | 1976 |
Population pharmacokinetic parameters for Bayesian monitoring of amikacin therapy in intensive care unit patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bayes Theorem; Humans; Infusions, Intravenous; Intensive Care Units; Middle Aged; Models, Statistical; Respiratory Tract Infections | 1992 |
Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates.
Topics: Amikacin; Bacteria; Cross Infection; Drug Resistance, Microbial; Humans; Meropenem; Microbial Sensitivity Tests; Respiratory Tract Infections; Thienamycins | 1992 |
[Intratracheal bolus of amikacin. An efficient adjuvant treatment of bronchial superinfection in major digestive surgery].
Topics: Administration, Inhalation; Amikacin; Cross Infection; Digestive System Surgical Procedures; Humans; Respiratory Tract Infections | 1991 |
[Amikacin in the treatment of infectious-inflammatory diseases in patients at a therapeutic hospital].
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Inflammation; Respiratory Tract Infections; Urinary Tract Infections | 1990 |
[Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cephamycins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
[Comparison of HAPA-B and amikacin in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Gentamicins; Humans; Middle Aged; Respiratory Tract Infections | 1986 |
Pulmonary nocardiosis in the acquired immunodeficiency syndrome. Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Cycloserine; Drug Therapy, Combination; Humans; Male; Minocycline; Nocardia asteroides; Nocardia Infections; Pneumonia, Pneumocystis; Pulmonary Alveoli; Radiography; Respiratory Tract Infections; Therapeutic Irrigation | 1986 |
Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.
Topics: Adolescent; Amikacin; Bronchi; Child; Child, Preschool; Cystic Fibrosis; Diffusion; Female; Half-Life; Humans; Kinetics; Male; Respiratory Tract Infections; Sputum | 1986 |
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis | 1985 |
Severe clinical manifestation of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency associated with two novel mutations: a case report.
Topics: Acidosis; Acyl Coenzyme A; Adipates; Carnitine; Diarrhea; Dicarboxylic Acids; Exome Sequencing; Fatal Outcome; Frameshift Mutation; Glutarates; Humans; Hydroxymethylglutaryl-CoA Synthase; Infant; Male; Mitochondria; Multiple Organ Failure; Mutation; Respiratory Tract Infections | 2019 |